Backward walking induced by L-5-hydroxytryptophan in mice

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• L-5-hydroxytryptophan (L-5HTP) is a precursor to serotonin.
• Understanding the behavioral effects of neurotransmitter precursors is crucial for pharmacology.

Purpose of the Study:

• To investigate the behavioral effects of L-5HTP administration in mice.
• To elucidate the neurochemical mechanisms underlying L-5HTP-induced behaviors.
• To establish a potential animal model for assessing central serotonergic activity.

Main Methods:

• Intraperitoneal administration of L-5HTP, D-5HTP, and L-DOPA to mice.
• Utilizing decarboxylase inhibitors, monoamine oxidase inhibitors (MAOIs), and receptor blockers.
• Administering intracerebral injections of L-5-hydroxytryptamine (5-HT).
• Testing the effects of 5-HT and dopamine (DA) receptor blockers, adrenergic blockers, antihistamines, anticholinergics, and selective serotonin reuptake inhibitors (SSRIs).

Main Results:

• L-5HTP induced dose-dependent backward walking in mice, unlike D-5HTP or L-DOPA.
• This behavior was blocked by a decarboxylase inhibitor and potentiated by MAOIs.
• Intracerebral 5-HT also induced backward walking, potentiated by MAOIs.
• The behavior was inhibited by 5-HT and DA receptor blockers but not by adrenergic, antihistamine, or anticholinergic drugs.
• SSRIs zimelidine and clomipramine potentiated the behavior, while desipramine did not.

Conclusions:

• Excess serotonin (5-HT) generated from L-5HTP stimulates central 5-HT receptors, causing backward walking.
• Dopamine (DA) is also implicated in this behavior.
• L-5HTP-induced backward walking serves as a valuable model for evaluating the central serotonergic activity of drugs.